Catalyst Wire Dossier Catalyst Wire Dossier

ChAd63 RH5

· University of Oxford
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ChAd63 RH5, covering 2015-12-03 to 2015-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5 [Phase 1]

See pricing